ArticleJournal of neurosurgery. Case lessons2026
Middle meningeal artery embolization of meningioma en plaque misdiagnosed as subdural hematoma: illustrative cases.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMeningioma en plaque (MEP) may rarely mimic subacute or chronic subdural hematoma (SDH) on noncontrast imaging. As middle meningeal artery (MMA) embolization becomes increasingly adopted for the management of SDH, misdiagnosis of an underlying dural tumor may delay definitive treatment and expose patients to interventions that could complicate subsequent resection. OBSERVATIONS: The authors present 2 cases of patients with MEP initially diagnosed as subacute SDH and treated with embolization. In both cases, embolization was performed prior to contrast-enhanced imaging, delaying recognition of the underlying tumor. Subsequent clinical and radiographic progression led to definitive diagnosis and surgical intervention. Intraoperatively, both lesions demonstrated marked cortical adherence and extensive invasion, resulting in challenging resections and postoperative neurological morbidity. These findings raise the possibility that embolization of an unrecognized MEP may alter tumor vascular dynamics and increase operative complexity. LESSONS: As MMA embolization becomes more widely used for presumed SDH, occult dural tumors such as MEP may increasingly be encountered as diagnostic pitfalls. In patients with atypical clinical presentation or unusual radiographic features, contrast-enhanced imaging should be obtained before or immediately after embolization to exclude an underlying neoplasm. Early recognition may prevent delays in care and avoid embolization-related vascular changes that could complicate definitive surgical treatment. https://thejns.org/doi/10.3171/CASE26492.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.